Business Context and Reporting Period
Company: LeMaitre Vascular, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 3, 2015
Event: Regulation FD Disclosure regarding an Investor and Analyst Meeting ("Analyst Day") held in New York, NY.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report serves as a disclosure of a corporate event rather than a financial statement.
Material Changes
No material changes to financial results or operations are reported in this document. The filing reiterates the financial outlook for the fourth quarter and full year 2015 previously announced on October 27, 2015.
Guidance, Outlook, and Management Commentary
- Analyst Day Overview: Management presented an overview of the Company's business, positioning, corporate strategy, and future growth opportunities.
- Financial Outlook: The Company reiterated its financial outlook for Q4 and full-year 2015, consistent with the October 27, 2015 announcement.
- Materials: Presentation materials (Exhibit 99.1) are available online at www.lemaitre.com/investor.
- Legal Status: The information furnished in this report and the attached exhibit is not deemed "filed" for purposes of the Securities Act of 1933 or the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings.
Investor Verification Checklist
- Verify the specific financial outlook figures announced on October 27, 2015, which were reiterated during this event.
- Review the attached Exhibit 99.1 (Analyst Day Presentation) for detailed strategic and growth opportunity data.
- Confirm the availability of the presentation materials on the company's investor relations website.